Results 21 to 30 of about 188 (163)

Use of conversion factors for the setting of MRLs of prothioconazole

open access: yesEFSA Journal, Volume 24, Issue 7, July 2026.
Abstract In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant Bayer AG Crop Science Division submitted a request to the competent national authority in France to use conversion factors for the setting of maximum residue levels (MRLs) for prothioconazole.
European Food Safety Authority (EFSA)   +18 more
wiley   +1 more source

Adherencia e impacto de la dieta sin gluten en niños con enfermedad celíaca [PDF]

open access: yesRevista chilena de pediatría, 2011
ABSTRACTAdherence and impact of gluten free diet in children with celiac disease The treatment of Celiac Disease (CD) is a strict and permanent gluten-free diet (GFD). Factors exist that in-fl uence adherence: motivation, information, costs, correct labeling and food availability.
BRAVO M, FRANCISCA, MUÑOZ F, MARÍA PAZ
openaire   +2 more sources

Poniendo al día la enfermedad celíaca

open access: yesRevista Médica Clínica Las Condes, 2011
El conocimiento en Enfermedad Celíaca (EC) ha mejorado sustancia/mente en las últimas décadas, cambiando muchos de los conceptos históricamente aceptados sobre este tema.
Q. Magdalena Araya, Dra.   +1 more
doaj   +1 more source

Addition of Supercritical CO2 Extracted Mussel Meal in Fishmeal‐Free Diets Improved Growth of Penaeus monodon juveniles

open access: yesAquaculture Research, Volume 2026, Issue 1, 2026.
Supercritical CO2 extracted mussel meal (SCMM) is a by‐product of green lipped mussel (Perna canaliculus) processing, following the removal of shell and therapeutically active lipids. The efficacy of SCMM as an ingredient in diets for Penaeus monodon was evaluated in two formulations using fishmeal (FM) and zero‐FM (ZFM) diets at 10% inclusion. Growth,
Ha H. Truong   +10 more
wiley   +1 more source

Actualización en el diagnóstico de la enfermedad celiaca

open access: yesAnales de la Facultad de Medicina, 2016
La enfermedad celiaca (EC) es una afección autoinmune multisistémica inducida por el gluten en personas genéticamente susceptibles. La presentación clínica clásica es con un síndrome diarreico crónico, aunque existen formas atípicas y silentes, lo cual ...
Raúl Emilio Real Delor
doaj   +1 more source

Modification of the existing maximum residue levels for acetamiprid in various crops and honey

open access: yesEFSA Journal, Volume 23, Issue 12, December 2025.
Abstract In accordance with Article 6 of Regulation (EC) No 396/2005, the applicants Nisso Chemical Europe GmbH and Nufarm Europe GmbH submitted two separate requests to the competent national authorities in the Netherlands and Austria, respectively, to modify the existing maximum residue levels (MRLs) for the active substance acetamiprid.
European Food Safety Authority (EFSA)   +18 more
wiley   +1 more source

Safety of UV‐treated oil from yellow mealworm (Tenebrio molitor larvae) as a novel food pursuant to Regulation (EU) 2015/2283

open access: yesEFSA Journal, Volume 23, Issue 11, November 2025.
Abstract Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on UV‐treated oil from yellow mealworm (Tenebrio molitor larvae) as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF is produced from farmed T.
EFSA Panel on Nutrition   +30 more
wiley   +1 more source

Enfermedad celiaca en niños del noroeste de México: características clínicas de 24 casos

open access: yesRevista de Gastroenterología de México, 2013
Antecedentes: La enfermedad celiaca (EC) es una enteropatía autoinmune inducida por el gluten del trigo dietético, con serias consecuencias si no se diagnostica y trata tempranamente.
N. Sotelo Cruz   +2 more
doaj   +1 more source

Modification of the existing maximum residue levels in barley, wheat and rye, and evaluation of Art.12 confirmatory data for pinoxaden

open access: yesEFSA Journal, Volume 23, Issue 11, November 2025.
Abstract In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant Syngenta Crop Protection AG submitted a request to the competent national authority in Italy to modify the existing maximum residue levels (MRLs) in barley, wheat and rye for pinoxaden.
European Food Safety Authority (EFSA)   +18 more
wiley   +1 more source

Enfermedad celíaca: un reto diagnóstico en Colombia

open access: yesRepertorio de Medicina y Cirugía, 2021
Introducción: la enfermedad celíaca (EC) es una patología sistémica inmunomediada por el gluten en la dieta en personas genéticamente susceptibles con un amplio rango de manifestaciones clínicas, respuesta serológica específica y daño variable de la ...
Juliana Suarez Correa   +3 more
doaj  

Home - About - Disclaimer - Privacy